Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
about
Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genesEstablishing a small animal model for evaluating protective immunity against mumps virus.Immunogenicity of mumps virus vaccine candidates matching circulating genotypes in the United States and China.
P2860
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@en
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@nl
type
label
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@en
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@nl
prefLabel
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@en
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@nl
P2093
P2860
P356
P1433
P1476
Immunogenicity of novel mumps vaccine candidates generated by genetic modification.
@en
P2093
Adrian Pickar
Shannon Phan
Zhenhai Chen
P2860
P304
P356
10.1128/JVI.02778-13
P407
P577
2013-12-18T00:00:00Z